Dissertation > Excellent graduate degree dissertation topics show

The Relationship and Possible Pathogenesis between Coronary Heart Disease and Nonalcoholic Fatty Liver Disease

Author: YueDongMei
Tutor: WangLingYan
School: Jilin University
Course: Internal Medicine
Keywords: Coronary heart disease Non - alcoholic fatty liver Alanine aminotransferase Atherosclerosis
CLC: R575.5
Type: Master's thesis
Year: 2011
Downloads: 90
Quote: 0
Read: Download Dissertation

Abstract


Objective: To investigate the non-alcoholic fatty liver disease and coronary heart disease relationship, possible mechanisms and ALT in which the possible role and significance. Method: observation group were a total of 105 cases were hospitalized with fatty liver of Chinese Medical Association the hepatology credits will learn group from February 2009 to February 2011, the Sino-Japanese Friendship Hospital, \\49 cases, 46 cases of women aged between 35-65 years old, with an average of (50.4 ± 10.4) years. Serum ALT levels observed group was divided into two sub-groups: A (ALT> 40IU / L) 50 Li; B group (ALT <40IU / L) 55. Application of U.S. BECKMAN SYNCHRON LX20 automatic biochemical analyzer using immune turbidimetric method all selected personnel of serum total cholesterol (TC), triglyceride (TG), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), serum apolipoprotein A1 (Apo A1), apolipoprotein B (Apo B), serum alanine aminotransferase (ALT), blood uric acid (UA), fasting glucose (GLU) and Calculate Apo A1 / Apo B values. Application American GE company vivid7, Color Doppler ultrasound detected in patients with carotid artery intima-media thickness (IMT). In results: ① observation group and the control group, the level of serum TC, TG, LDL-C was significantly higher than the normal control group, the difference was significant (P lt; 0.05); HDL-C levels below the normal control group, a significant difference (P lt; 0.05); A group and B group, TC, TG, LDL-C, Apo B levels tended to increase HDL-C, Apo A1 level, Apo A1 / Apo B value compared to the decline, but the difference was not statistically significant (P gt; 0.05). ② ALT levels and TG levels were positively correlated (r = 0.166, P lt; 0.05). (3) observation group compared with the control group, fasting GLU levels were significantly higher than the normal control group, the difference was significant (P lt; 0.05); A group and B group, fasting GLU increased, but no statistical difference significance (P gt ; 0.05). (4) observation group compared with the control group, serum uric acid was significantly higher than the normal control group, a statistically significant (P lt; 0.01); A group and B group, the blood uric acid level is higher than group B, a significant difference (P lt; 0.01 ). (5) the observation group compared with the control group, IMT: group A (1.27 ± 0.06) mm in group B (0.75 ± 0.03) mm, the control group (0.29 ± 0.03) mm, were significantly different (P lt; 0.05); neck The number of arterial plaque: A group (2.23 ± 1.35), B group (1.67 ± 1.42), the control group (1.30 ± 1.56), were statistically significant (P lt; 0.05); carotid plaque detection rate of group A : 79.2%, B group: 68.4%, control group 55.4%, There was a significant difference (P lt; 0.05). Group A compared with group B, IMT: group A (1.27 ± 0.06) mm, group B (0.75 ± 0.03) mm, the difference was significantly (P lt; 0.05); number of carotid artery plaque: A group (2.23 ± 1.35) group B (1.67 ± 1.42) was statistically significant (P lt; 0.05); carotid plaque detection rate in group A: 79.2%, group B: 68.4%, a significant difference (P lt; 0.05). Conclusion: ① non-alcoholic fatty liver incidence of coronary heart disease in patients with significantly elevated serum ALT levels. ② ALT levels and the severity of coronary heart disease. ③ trigger the possible mechanisms of lipid metabolism disorders, hyperuricemia, hyperglycemia and other risk factors for atherosclerosis. ④ non-alcoholic fatty liver disease may be an independent risk factor for coronary heart disease.

Related Dissertations

  1. Effect of High Glucose on Chemokine Ligand 16 (CXCL16) Expression and Secretion in THP-1 Macrophages and Intervention of Aspirin in the Activity,R587.2
  2. Role of G31P in Smooth Muscle Migration of A7r5 Cells Induced by Interleukin-8,R363
  3. Correlative Study on Plasma Level of Resistin in Patients with Coronary Atherosclerosis Disease,R541.4
  4. Association of Interleukin-6 Gene Polymorphisms with Susceptibility to Coronary Heart Disease in Asian Populations: a Meta-analysis,R541.4
  5. Relationship between Carotid Artery Atherosclerosis and Coronary Artery Lesion in Patients with Coronary Heart Disease,R541.4
  6. Relationship and Significance of Gene Transcription Profiles in Rat Liver Regeneration and Non-Alcoholic Fatty Liver Disease Occurrence,R575.5
  7. Risk Factors of Early Onset Type 2 Diabetes with Non-alcoholic Fatty Liver Disease,R587.1
  8. The Relationship of Serum Adiponectin、Nitric Oxide Synthase and Carotid Atherosclerosis in Patients with Acute Cerebral Infarction,R743.33
  9. Heart rate variability and coronary artery disease and prognosis of acute myocardial infarction,R541.4
  10. The Correlation between Type D Personality and Anxiety, Depression in Patients with Coronary Heart Disease,R473.5
  11. Migration of VSMC and SPC by Expression of Sdf-1αin VSMC on the Effect of ox-LDL,R363
  12. The Relationship between the Plasma Level of HSP70 and Coronary Heart Disease,R541.4
  13. Anti-inflammatory effect of fusion protein anticoagulant dual function of TAP-SSL5,R543.5
  14. The Study on Anti-atherosclerosis Effect and Its Mechanisms of Housefly Maggot in ApoE-/- Mice,R965
  15. Study on the Association between CETP Gene Polymorphism and Cerebral Infarction of Han Population in Hunan Province,R743.33
  16. The prospective study of risk factors for disease of the heart and brain together and gathered,R743
  17. The Change in the Serum Levels of Myeloperoxidase and Lipoxin A4 in Coronary Heart Disease Patients with Depression and/or Anxiety,R541.4
  18. Stable angina pectoris ( phlegm and permits) Integrative Medicine Outcome Assessment System,R541.4
  19. Coronary syndrome factor research - On toxin in the pathogenesis of coronary heart disease,R259
  20. Clinical observation of Tongmai drop Turbidity treatment of angina pectoris phlegm stasis syndrome with hyperlipidemia,R259
  21. Of coronary heart disease syndrome factor,R259

CLC: > Medicine, health > Internal Medicine > Digestive and abdominal diseases > Liver and gall bladder disease > Liver metabolic disorders
© 2012 www.DissertationTopic.Net  Mobile